Lecanemab: First Approval

Sheridan M. Hoy

View at source ↗Article144 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1007/s40265-023-01851-2
Published
Mar 1, 2023
Venue
Drugs
DOI
10.1007/s40265-023-01851-2
PubMed
36856953
Categories
Alzheimer's disease research and treatments
License
cc-by-nc
Provenance
openalex

Topics